UNITED STATES
                       SECURITIES AND EXCHANGE COMMISSION
                              Washington, DC 20549

                                    FORM 8-K

                             CURRENT REPORT Pursuant
                          to Section 13 or 15(d) of the
                         Securities Exchange Act of 1934

        Date of report (Date of earliest event reported) October 21, 2004

                         TEMPUR-PEDIC INTERNATIONAL INC.
             (Exact Name of Registrant as Specified in Its Charter)

          Delaware                     001-31922                  33-1022198
(State or other jurisdiction     (Commission File No.)         (I.R.S. Employer
      of incorporation)                                      Identification No.)

                               1713 Jaggie Fox Way
                            Lexington, Kentucky 40511
               (Address of principal executive offices) (Zip Code)

                                 (800) 878-8889
              (Registrant's telephone number, including area code)

                                       N/A
          (Former name or former address, if changed since last report)

      Check the  appropriate  box below if the Form 8-K  filing is  intended  to
simultaneously  satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):

      |_| Written  communications  pursuant to Rule 425 under the Securities Act
(17 CFR 230.425)

      |_| Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17
CFR 240.14a-12)

      |_|  Pre-commencement  communications  pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))

      |_|  Pre-commencement  communications  pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))

Item 2.02. Results of Operations and Financial Condition. On October 21, 2004, Tempur-Pedic International Inc. issued a press release to announce its financial results for the third quarter ended September 30, 2004, including certain non-GAAP financial results, and to raise its guidance for the full year 2004. This press release includes reconciliations of such non-GAAP financial measures to the most directly comparable GAAP financial measures and is furnished herewith as Exhibit 99.1 and incorporated by reference herein. The information in this report (including Exhibit 99.1) shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act") or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities Act of 1933, as amended, or the Exchange Act, except as shall be expressly set forth by specific reference in such filing. Item 7.01. Regulation FD Disclosure. The information furnished under Item 2.02 of this Form 8-K, including Exhibit 99.1 furnished herewith, is hereby incorporated by reference under this Item 7.01 as if fully set forth herein. Item 9.01. Financial Statements and Exhibits. (a) Financial Statements of Businesses Acquired. Not applicable. (b) Pro Forma Financial Information. Not applicable. (c) Exhibits. 99.1. Press release dated October 21, 2004, titled "Tempur-Pedic International Reports Record Third Quarter Revenue and Earnings; Raises Guidance for 2004".

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Date: October 21, 2004 Tempur-Pedic International Inc. By: /s/ Robert B. Trussell, Jr. -------------------------------------------- Name: Robert B. Trussell, Jr. Title: President and Chief Executive Officer

EXHIBIT INDEX Exhibit Description - ------- ----------------------------------------------------------------------- 99.1 Press release dated October 21, 2004, titled "Tempur-Pedic International Reports Record Third Quarter Revenue and Earnings; Raises Guidance for 2004".

                                                                   Exhibit 99.1

    Tempur-Pedic International Reports Record Third Quarter Net Sales and
                      Earnings; Raises Guidance for 2004

  Achieves Net Sales Growth of 47%, Pro Forma Net Income of $0.23 Per Share,
                      GAAP Net Income of $0.22 Per Share

                 Provides Net Sales and EPS Guidance for 2005

    LEXINGTON, Ky., Oct. 21 /PRNewswire-FirstCall/ -- Tempur-Pedic
International Inc. (NYSE: TPX), the market-leading manufacturer, marketer and
distributor of premium visco-elastic mattresses and pillows worldwide, today
announced record net sales and earnings for the third quarter ended September
30, 2004.

    Third Quarter 2004 Highlights

     * Pro forma net income rose 93% to $23.7 million or $0.23 per diluted
       share from $12.3 million or $0.13 per diluted share in the third
       quarter of 2003.  The Company reported third quarter net income under
       GAAP of $22.4 million, or $0.22 per diluted share compared to $0.3
       million or $0.00 per diluted share in the third quarter of 2003.

     * Net sales rose 47% to $181.7 million from $123.6 million in the third
       quarter of 2003.

     * Operating margin increased to 24% from 18% in the third quarter of
       2003.

     * Net sales in the Company's retail channel increased 77% in the U.S. and
       63% worldwide.

     * Mattress net sales increased 69% on unit growth of 52%.

    "The third quarter was another outstanding period for Tempur-Pedic
International," said Robert Trussell, President and Chief Executive Officer.
"Our record financial performance exceeded our internal expectations,
reflecting consumers' growing interest and awareness of our brand.  It also
reflects management's ability to execute on the Company's key strategies and
growth plans.
    "During the quarter, we grew across all four of our sales channels, with
particularly strong increases in furniture retail store sales.  We added a
total of approximately 300 new furniture retail stores in the U.S., bringing
total U.S. furniture stores to 3,900 as of September 30, 2004.
Internationally, we added placements in approximately 280 stores during the
quarter.  Total mattress net sales rose 69% in the third quarter of 2004,
driven primarily by the growth in net sales to furniture retail stores and the
continuing success of our newest premium models, and we continued to achieve
significant productivity improvements in our manufacturing operations and to
leverage our fixed operating expenses.
    "Tempur-Pedic International has developed an exceptional line of products
with outstanding customer satisfaction, global distribution in over 60
countries, and a highly effective business model.  Our goal is to 'change the
way the world sleeps' and, in the process, to take full advantage of the many
growth opportunities that exist.  After taking into account bedding industry
seasonal trends and our Company's strong results, we are raising our financial
guidance for the full year 2004.  We currently expect the Company's net sales
to range between $660 million -- $665 million, and pro forma diluted net
income per share to range between $0.77 -- $0.79.  In addition, based on the
continued strong performance of the business, we currently estimate net sales
for 2005 will range between $810 million -- $830 million and pro forma diluted
net income per share for 2005 will range between $0.95 -- $1.00."
    The Company notes that its expectations are based on information available
at the time of this release, and are subject to changing conditions, many of
which are outside the Company's control.

    Third Quarter 2004 Financial Summary
    Third quarter 2004 net sales were $181.7 million, 47% higher than third
quarter 2003 net sales. The Company also reported third quarter pro forma net
income of $23.7 million, or $0.23 per diluted share, compared with pro forma
net income of $12.3 million, or $0.13 per diluted share, for the third quarter
2003, which represents an increase in pro forma net income of 93% and 77% on a
pro forma per diluted share basis.  The Company reported third quarter net
income under Generally Accepted Accounting Principles ("GAAP") of $22.4
million, or $0.22 per diluted share compared to $0.3 million or $0.00 per
diluted share in the third quarter of 2003. For a full discussion of the pro
forma adjustments, see the Supplemental Information included later in this
press release.

    Conference Call Information
    As previously announced, Tempur-Pedic International is hosting a live
conference call featuring President and Chief Executive Officer Robert
Trussell and Chief Financial Officer Dale Williams to discuss third quarter
results today, October 21, at 5:00 p.m. Eastern Time (2 p.m. Pacific Time).
The dial-in number for the conference call is 877-278-2335 or 706-634-0167.
The call is also being webcast, and can be accessed at
http://www.tempurpedic.com.
    For those who cannot listen to the live broadcast, a replay of the call
will be available from October 21, 2004 at 8:00 p.m. Eastern Time through
October 28, 2004, and can be accessed by dialing 706-645-9291, conference ID
#1386982.
    An archived webcast will also be available on the Tempur-Pedic
International investor relations website at http://www.tempurpedic.com/ir.

    Forward-Looking Statements
    This release contains "forward-looking statements," which include
information concerning one or more of the Company's plans, objectives, goals,
strategies, future revenues and performance, capital expenditures, financing
needs and other information that is not historical information.  When used in
this release, the words "estimates," "expects," "anticipates," "projects,"
"plans," "intends," "believes," and variations of such words or similar
expressions are intended to identify forward-looking statements.  All forward-
looking statements, including, without limitation, management's expectations
regarding continued growth and its net sales and pro forma and GAAP net income
for 2004 and 2005, are based upon current expectations and beliefs and various
assumptions.  There can be no assurance that the Company will realize these
expectations or that these beliefs will prove correct.
    There are a number of risks and uncertainties that could cause actual
results to differ materially from the forward-looking statements contained in
this release. Numerous factors, many of which are beyond the Company's
control, could cause actual results to differ materially from those expressed
as forward-looking statements.  Certain of these risk factors are discussed in
the Company's filings with the Securities and Exchange Commission, including
without limitation the Company's annual report on Form 10-K under the headings
"Special Note Regarding Forward Looking Statements" and "Business-Risk
Factors".  Any forward-looking statement speaks only as of the date on which
it is made, and the Company undertakes no obligation to update any forward-
looking statements to reflect events or circumstances after the date on which
it is made or to reflect the occurrence of anticipated or unanticipated events
or circumstances

    About the Company
    Tempur-Pedic International Inc. (NYSE: TPX) manufactures and distributes
Swedish Mattresses and Neck Pillows(TM) made from the revolutionary Tempur(R)
pressure-relieving material, a visco-elastic material that conforms to the
body to provide support and help alleviate pressure points. Products are
currently sold in 60 countries under the Tempur(R) and Tempur-Pedic(R) brand
names. World headquarters for Tempur-Pedic International are in Lexington, KY.

    For more information, visit http://www.tempurpedic.com or call
800-805-3635. To visit Tempur-Pedic's celebrity connection, visit
http://www.mattressofthestars.com.


               TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
                      Consolidated Statements of Income

    ($ in thousands, except per share data)

                       Three Months Ended         Nine Months Ended
                         September 30,               September 30,
                                          Chg%                       Chg%
                        2004      2003             2004      2003
                  (unaudited)(unaudited)     (unaudited)(unaudited)


    Net sales       $181,737  $123,555     47% $486,460  $342,359     42%
    Cost of sales     85,657    60,170          228,228   158,805

    Gross profit      96,080    63,385     52%  258,232   183,554     41%

    Selling expenses  34,911    26,429          101,519    75,499
    General and
     administrative
     expenses         17,683    13,452           48,974    34,655

    Research and
     development
     expenses            651       777            1,381     1,191

    Operating income  42,835    22,727     89%  106,358    72,209     47%

    Other income
     (expense), net:
    Interest expense,
     net              (6,220)   (5,584)         (17,865)  (13,743)
    Loss on debt
     extinguishment       --   (13,669)          (5,381)  (13,669)
    Other income
     (expense), net     (175)     (969)              21    (1,476)
    Total other expense,
     net              (6,395)  (20,222)         (23,225)  (28,888)

    Income before
     income taxes     36,440     2,505           83,133    43,321     92%

    Income tax
     provision        14,029     2,180           32,006    17,331

    Net income       $22,411     $ 325          $51,127   $25,990     97%

    Basic earnings
     per share         $0.23     $0.04            $0.52     $3.21    (84%)

    Diluted earnings
     per share         $0.22     $0.00            $0.50      $.28     79%

    Dilutive weighted
     average shares
      outstanding
     (in thousands)  103,036    96,005          102,933    93,143


    Supplemental Information

    Pro Forma Net Income and Other Financial Data
    To further provide investors useful information, pro forma net income is
presented and represents the Company's GAAP net income before non-cash stock-
based compensation expense of $1.3 million and $1.6 million for the three
months ended September 30, 2004 and 2003, respectively, and $4.3 million and
$1.7 million for the nine months ended September 30, 2004 and 2003,
respectively.  The Company has unearned non-cash stock-based compensation of
$4.7 million as of September 30, 2004 that will be recognized as expense in
future periods.  In addition to these pro forma adjustments, GAAP net income
includes, and pro forma net income excludes, a loss on debt extinguishment
totaling $3.3 million, net of tax, for the nine months ended September 30,
2004 relating to the Company's redemption in January 2004 of $52.5 million
aggregate principal amount of the outstanding 10 1/4% Senior Subordinated
Notes due 2010 issued by its subsidiaries Tempur-Pedic, Inc. and Tempur
Production USA, Inc.  For the three and nine months ended September 30, 2003,
GAAP net income includes, and pro forma net income excludes, transaction
related expenses totaling $10.4 million, net of tax, relating to the write-off
of deferred financing fess, original issue discount and prepayment penalties
relating to the Company's re-capitalization in August 2003, and these amounts
are included in loss on debt extinguishment, net of tax.
    The Company believes that excluding non-cash stock-based compensation
expense and loss on debt extinguishment provides a measure that is more
representative of ongoing costs and therefore more comparable to the Company's
historical operations.  The following is a reconciliation of GAAP net income
to pro forma net income and per share amounts:


               TEMPUR-PEDIC INTERNATIONAL INC. AND SUBSIDIARIES
Reconciliation of GAAP Net Income to Pro Forma Net Income, and Other Financial
                                     Data

    ($ in thousands, except per share data)

                            Three Months Ended         Nine Months Ended
                               September 30,             September 30,
                             2004         2003         2004         2003
                         (unaudited)  (unaudited)  (unaudited)  (unaudited)

    GAAP net income        $22,411         $325     $ 51,127      $25,990

      Non-cash stock-based
       compensation expense  1,266        1,557        4,256        1,720
      Loss on debt
       extinguishment,
       net of tax               --       10,401        3,309       10,401
    Pro forma net income   $23,677     $ 12,283     $ 58,692      $38,111

    GAAP net income per
     share, diluted          $0.22        $0.00        $0.50        $0.28
      Non-cash stock-based
       compensation expense   0.01         0.02         0.04         0.02
      Loss on debt
       extinguishment,
       net of tax             0.00         0.11         0.03         0.11

    Pro forma net income
     per share, diluted      $0.23        $0.13        $0.57        $0.41

    Other financial data
    Depreciation and
     amortization           $7,229       $6,413     $ 21,194      $16,316

    Net debt               270,722      369,485      270,722      369,485

    Summary of Channel Sales
    The Company generates sales through four distribution channels: retail,
direct, healthcare and third party.  The retail channel sells to furniture,
specialty and department stores globally.  The direct channel sells directly
to consumers.  The healthcare channel sells to hospitals, nursing homes,
healthcare professionals and medical retailers.  The third party channel sells
to distributors in countries where Tempur-Pedic International does not operate
its own distribution company.
    The following table highlights net sales information, by channel and by
segment, for the third quarter:


                      CONSOLIDATED        DOMESTIC           INTERNATIONAL
                  Three Months Ended  Three Months Ended   Three Months Ended
                      September 30,     September 30,        September 30,
    ($ in thousands)   (unaudited)       (unaudited)         (unaudited)
                     2004      2003     2004     2003      2004       2003
    By Sales
     Channel

    Retail       $133,429   $82,042  $93,260  $52,806   $40,169    $29,236
    Direct         24,767    20,762   21,300   18,340     3,467      2,422
    Healthcare     11,442    10,730    2,793    2,622     8,649      8,108
    Third Party    12,099    10,021    2,206    1,658     9,893      8,363

    By Segment
    Domestic     $119,559   $75,426
    International  62,178    48,129


    Summary of Product Sales
    A summary of net sales by product is reported below.

                        CONSOLIDATED         DOMESTIC          INTERNATIONAL
    ($ in thousands) Three Months Ended  Three Months Ended Three Months Ended
                         September 30,      September 30,       September 30,
                          (unaudited)        (unaudited)         (unaudited)
                        2004      2003      2004     2003       2004     2003
    Net Sales

    Mattresses      $119,754   $70,668   $85,406  $49,504    $34,348  $21,164
    Pillows           33,036    31,385    14,076   12,838     18,960   18,547
    Other             28,947    21,502    20,077   13,084      8,870    8,418

SOURCE  Tempur-Pedic International Inc.
    -0-                             10/21/2004
    /CONTACT:  Dale Williams Chief Financial Officer of Tempur-Pedic
International Inc.,
1-800-805-3635/
    /Web site:  http://www.tempurpedic.com
                http://www.mattressofthestars.com /
    (TPX)

CO:  Tempur-Pedic International Inc.
ST:  Kentucky
IN:  HOU CHM
SU:  ERN CCA